KEW Stock Overview

Designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. More details

KEW fundamental analysis
Snowflake Score
Valuation	4/6
Future Growth	0/6
Past Performance	6/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 95.7% below our estimate of its fair value

Earnings grew by 170.4% over the past year

Risk Analysis

Volatile share price over the past 3 months compared to the German market

My Notes

Capture your thoughts, links and company narrative

Kewaunee Scientific Corporation Competitors

PULSION Medical Systems

MUN:PUS

€133.6m

Stratec

XTRA:SBS

€343.4m

Drägerwerk KGaA

XTRA:DRW3

€805.1m

Eckert & Ziegler

XTRA:EUZ

€943.9m

Price History & Performance

Summary of share price highs, lows and changes for Kewaunee Scientific
Historical stock prices
Current Share Price	US$51.00
52 Week High	US$51.50
52 Week Low	US$28.00
Beta	0.83
1 Month Change	43.26%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	80.85%

Recent updates

Shareholder Returns

	KEW	DE Medical Equipment	DE Market
7D	31.4%	-2.2%	-1.1%
1Y	n/a	-7.2%	8.1%

Return vs Industry: Insufficient data to determine how KEW performed against the German Medical Equipment industry.

Return vs Market: Insufficient data to determine how KEW performed against the German Market.

Price Volatility

Is KEW's price volatile compared to industry and market?
KEW volatility
KEW Average Weekly Movement	11.3%
Medical Equipment Industry Average Movement	6.7%
Market Average Movement	4.9%
10% most volatile stocks in DE Market	11.8%
10% least volatile stocks in DE Market	2.5%

Stable Share Price: KEW's share price has been volatile over the past 3 months compared to the German market.

Volatility Over Time: Insufficient data to determine KEW's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
1906	1,006	Thomas Hull	www.kewaunee.com

Kewaunee Scientific Corporation designs, manufactures, and installs laboratory, healthcare, and technical furniture and infrastructure products. The company operates through two segments: Domestic and International. Its products include steel and wood casework, fume hoods, adaptable modular systems, moveable workstations, stand-alone benches, biological safety cabinets, and epoxy resin work surfaces and sinks.

Kewaunee Scientific Corporation Fundamentals Summary

How do Kewaunee Scientific's earnings and revenue compare to its market cap?
KEW fundamental statistics
Market cap	€148.94m
Earnings (TTM)	€18.09m
Revenue (TTM)	€192.63m

8.1x

P/E Ratio

0.8x

P/S Ratio

Is KEW overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
KEW income statement (TTM)
Revenue	US$199.64m
Cost of Revenue	US$146.53m
Gross Profit	US$53.11m
Other Expenses	US$34.36m
Earnings	US$18.75m

Last Reported Earnings

Oct 31, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	6.53
Gross Margin	26.60%
Net Profit Margin	9.39%
Debt/Equity Ratio	47.1%

How did KEW perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/18 03:00
End of Day Share Price	2024/12/18 00:00
Earnings	2024/10/31
Annual Earnings	2024/04/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Kewaunee Scientific Corporation is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
null null	CG Capital

Kewaunee Scientific DB:KEW Stock Report